Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

NCT06438263

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Fortrea Clinical Research Unit - Daytona Beach Daytona Beach, Florida, United States
  • Fortrea Clinical Research Unit - Dallas Dallas, Texas, United States
  • Fortrea Clinical Research Unit Inc. - Madison Madison, Wisconsin, United States
View Trial Details
Completed

A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT05704738

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Cahaba Dermatology and Skin Health Center Birmingham, Alabama, United States
  • AllerVie Clinical Research- Cullman Cullman, Alabama, United States
  • Eclipse Clinical Research Tucson, Arizona, United States
  • Arkansas Research Trials, LLC North Little Rock, Arkansas, United States
View all 246 locations
View Trial Details
Completed

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

NCT06173284

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Dermatology Hospital of Jiangxi Province Nanchang, Jiangxi, China
  • Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • The Fourth Affiliated Hospital Zhejiang University School of Medicine Jinhua, Zhejiang, China
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT03422822

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Dermatology Research Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham Hospital Outreach Lab Birmingham, Alabama, United States
View all 539 locations
View Trial Details
Completed

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

NCT05958407

Conditions
Atopic Dermatitis, Atopic Hand Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • LEO Pharma Investigational Site Birmingham, Alabama, United States
  • LEO Pharma Investigational Site Fort Smith, Arkansas, United States
  • LEO Pharma Investigational Site Fountain Valley, California, United States
  • LEO Pharma Investigational Site Los Angeles, California, United States
View all 69 locations
View Trial Details

Related conditions